The pace of AI continues to be staggering. From simple pattern recognition systems to large language models (LLMs), and now as we move into the physical AI reality, the power of these systems ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Advanced data visualization and analytics have become central to enterprise IT strategies as organizations face rapid data growth from cloud services, software-as-a-service applications, edge devices, ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Harrison Barnes used a visualization tool to help him improve. Illustration: Dan Goldfarb / The Athletic; Logan Riely / NBAE / Getty Images Editor’s note: This story is part of Peak, The Athletic’s ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

I am participating in Hactoberfest 2025. Currently recursion is under coming soon. I can design the cards on fundamental recursion problems and design call stack and tree. If you find this issue ...